Cancer · 2001 · 110 citations · 24 references
MedicineOncologyMetastasisMolecular OncologyNeoplasiaAngiogenesisAngiogenesis In CancerEsophageal CancerMalignant NeoplasmsMalignant TumorsSquamous Cell CarcinomaAngiogenesis In NeoplasmsEsophageal Cancer StagingLymph Node Metastasis BiomarkersTherapy Response EvaluationTumor Burden MeasurementTumor Depth Of InvasionTumor Size PrognosisVascular Endothelial Growth Factor
BACKGROUND: Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis in malignant tumors. An increased in the serum VEGF concentration (S-VEGF) has been found in patients with various solid tumors and appears to be correlated with tumor burden. The objective of the current study was to determine the correlation between pretreatment S-VEGF and clinicopathologic features in patients with esophageal squamous cell carcinoma. METHODS: Pretreatment S-VEGF was measured by enzyme-linked immunoadsorbent assay in 24 healthy controls and 96 patients with esophageal squamous cell carcinoma (82 patients with primary tumors and 14 with recurrent tumors). Chemoradiotherapy was performed in 35 patients followed by response evaluation. RESULTS: S-VEGF was found to be significantly elevated in patients with primary esophageal carcinoma (P = 0.0011). Significant differences were observed when S-VEGF was categorized by tumor size (P = 0.0002), tumor depth (P = 0.0082), lymph node metastasis (P = 0.0002), distant metastasis (P = 0.028), and International Union Against Cancer TNM stage (P < 0.0001). The patients who achieved a partial or complete response to chemoradiotherapy showed significantly less S-VEGF than those patients who were nonresponders (P = 0.018). A high (> 451 pg/mL) S-VEGF level was associated with poor survival (P < 0.001). Multivariate analysis found S-VEGF to be a significant and independent prognostic factor (P < 0.001). CONCLUSIONS: In the current study, a high S-VEGF was found to be associated with tumor progression, poor treatment response, and poor survival in patients with squamous cell carcinoma of the esophagus.
24
Intratumor microvessel density as a prognostic factor in cancer.
Noel Weidner · PubMed · 1995 · 876 citations
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Tanja Veikkola, Marika J. Karkkainen, Lena Claesson‐Welsh et al. · PubMed · 2000 · 745 citations
Medicine, Cancer Biology, Oncology +16
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
Kiyoshi Maeda, Yong Suk Chung, Yoshinari Ogawa et al. · Cancer · 1996 · 633 citations